SUPERNUS PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Supernus Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2022.
  • Supernus Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $59.6M, a 15.5% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $59.6M -$10.9M -15.5% Dec 31, 2022 10-K 2023-03-09
Q4 2021 $70.5M +$69.9M +12018% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $582K +$571K Dec 31, 2020 10-K 2023-03-09
Q2 2020 $70.5M Jun 9, 2020 10-K 2022-04-13
Q4 2019 $11K* +$2K Dec 31, 2019 10-K 2023-03-09
Q4 2018 $9K* Dec 31, 2018 10-K 2022-04-13
Q4 2015 $60.1M -$1.79M -2.89% Dec 31, 2015 10-K 2017-03-16
Q4 2014 $61.9M +$2.05M +3.43% Dec 31, 2014 10-K/A 2017-01-20
Q4 2013 $59.8M +$21.6M +56.5% Dec 31, 2013 10-K 2015-03-12
Q4 2012 $38.2M +$17.7M +86.2% Dec 31, 2012 10-K 2014-03-21
Q4 2011 $20.5M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.